Novartis is now responsible for worldwide development ... to treat heart failure, and diabetes drug Galvus (vildagliptin) through its cardio-metabolic division, and is looking to expand its ...

Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities. The move comes after President Trump earlier this week threatened "major" tariffs on ...